Stock Report

Download full stock data and analysis for free Last Updated: 06-Nov-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Krebs Biochemicals Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: KREBSBIO | BSE: 524518

₹57.86

up-down-arrow ₹0.76 (1.33%)

As on 05-Nov-2026IST

Market cap

info icon

₹121 Cr

Revenue (TTM)

info icon

₹27 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

-0.7

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -17.10 38.95 -1.32 -16.43 -9.47
EBIT -363.78 19.99 62.50 15.57 11.60
Net Profit -117.18 12.11 51.40 11.23 10.19
EPS -117.18 12.11 51.41 11.23 10.39
Book Value -- -- -11.29 -28.62 -202.97
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-26Mar-25
EBIT-Margin info -43.63-48.25-30.04-50.03-50.14
Net Margin info -55.24-57.14-45.94-65.74-61.20
Return on equity info 0.000.00--0.000.00
Return on Capital info -21.43-30.05---15.38-29.92
Return on Assets info -12.29-15.19-8.17-10.19-15.52
Debt to Equity (x) info -----0.91-1.38-1.45

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Krebs Biochemicals
--
-15.38
-29.92
-18.99
-28.59
Peer Median
--
14.03
16.46
15.49
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

--

--

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Krebs Biochemicals
--
--
--
--
--
Peer Median
10.71
13.45
13.87
14.72
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-8.17

Lower than Peers by 15.98

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Krebs Biochemicals
-8.17
-10.19
-15.52
-11.17
-13.54
Peer Median
7.81
7.94
8.04
7.19
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-30.04

Lower than Peers by 39.64

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Krebs Biochemicals
-30.04
-50.03
-50.14
-30.72
-42.85
Peer Median
9.60
20.82
10.05
10.28
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-45.94

Lower than Peers by 56.12

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Krebs Biochemicals
-45.94
-65.74
-61.20
-38.78
-46.81
Peer Median
10.17
11.88
9.11
6.78
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Krebs Biochemicals
0.00
-44.29
-46.75
-25.71
-34.78
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-1.32

Lower than Peers by 8.48

Year on year growth in net sales

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Krebs Biochemicals
-1.32
-45.21
-14.10
-3.29
-12.68
Peer Median
7.17
19.32
7.17
10.56
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

62.50

Higher than Peers by 58.58

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Krebs Biochemicals
62.50
45.33
-40.21
30.66
44.56
Peer Median
3.92
30.05
12.05
6.17
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

51.40

Higher than Peers by 37.99

Year on year growth in profit after tax

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Krebs Biochemicals
51.40
37.14
-36.55
20.10
44.55
Peer Median
13.41
26.56
22.15
27.97
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

51.41

Higher than Peers by 44.69

Year on year growth in earnings per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Krebs Biochemicals
51.41
37.14
-36.55
20.10
44.55
Peer Median
6.71
22.47
8.80
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Krebs Biochemicals
--
-11.29
-22.67
-19.86
-32.45
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

-0.91

Lower than Peers by 0.92

Total debt / Net worth

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Krebs Biochemicals
-0.91
-1.38
-1.45
-1.62
-1.84
Peer Median
0.02
0.17
0.03
0.05
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Krebs Biochemicals
--
-0.38
-0.35
-0.08
-0.10
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

0.06

Lower than Peers by 2.42

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Krebs Biochemicals
0.06
0.09
0.10
0.28
0.33
Peer Median
2.48
2.23
2.20
1.93
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

0.03

Lower than Peers by 1.73

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Krebs Biochemicals
0.03
0.03
0.04
0.12
0.08
Peer Median
1.76
1.70
1.72
1.59
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-0.78

Lower than Peers by 11.13

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Krebs Biochemicals
-0.78
-1.39
-3.55
-3.21
-7.30
Peer Median
10.35
11.31
12.28
12.45
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

0.01

Lower than Peers by 27.15

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Krebs Biochemicals
0.01
0.02
0.12
3.77
1.01
Peer Median
27.17
32.77
26.23
23.97
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.16

Lower than Peers by 0.50

Sales / Average Total Assets

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Krebs Biochemicals
0.16
0.14
0.25
0.29
0.29
Peer Median
0.66
0.64
0.74
0.88
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Krebs Biochemicals
--
0.42
8.23
8.79
4.91
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Krebs Biochemicals
--
90.24
66.69
78.69
131.30
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Krebs Biochemicals
--
--
1,219.44
948.90
378.02
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Krebs Biochemicals
--
90.66
-1,144.52
-861.42
-241.81
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

-9.07

Lower than Peers by 55.47

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Krebs Biochemicals
-9.07
--
--
--
--
Peer Median
46.40
51.73
39.17
40.74
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

-0.71

Lower than Peers by 4.55

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Krebs Biochemicals
-0.71
-0.53
-0.98
-1.10
-1.22
Peer Median
3.84
4.97
3.61
3.87
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Krebs Biochemicals
--
--
--
--
--
Peer Median
0.13
0.12
0.19
0.20
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

657.74

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Krebs Biochemicals
657.74
-90.82
-24.86
-39.30
-20.11
Peer Median
--
44.38
28.79
25.41
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

121

Lower than Peers by 5,284

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Krebs Biochemicals
121
86
144
132
122
Peer Median
5,406
5,447
3,944
2,959
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...

Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds